379 related articles for article (PubMed ID: 18192740)
1. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results.
Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
Water Sci Technol; 2008; 57(1):49-56. PubMed ID: 18192740
[TBL] [Abstract][Full Text] [Related]
2. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
4. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceuticals and personal care products in effluent matrices: A survey of transformation and removal during wastewater treatment and implications for wastewater management.
Oulton RL; Kohn T; Cwiertny DM
J Environ Monit; 2010 Nov; 12(11):1956-78. PubMed ID: 20938541
[TBL] [Abstract][Full Text] [Related]
6. Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan.
Okuda T; Kobayashi Y; Nagao R; Yamashita N; Tanaka H; Tanaka S; Fujii S; Konishi C; Houwa I
Water Sci Technol; 2008; 57(1):65-71. PubMed ID: 18192742
[TBL] [Abstract][Full Text] [Related]
7. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes.
Sui Q; Huang J; Deng S; Chen W; Yu G
Environ Sci Technol; 2011 Apr; 45(8):3341-8. PubMed ID: 21428396
[TBL] [Abstract][Full Text] [Related]
8. The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants.
Clara M; Kreuzinger N; Strenn B; Gans O; Kroiss H
Water Res; 2005 Jan; 39(1):97-106. PubMed ID: 15607169
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters.
Hijosa-Valsero M; Matamoros V; Sidrach-Cardona R; Martín-Villacorta J; Bécares E; Bayona JM
Water Res; 2010 Jun; 44(12):3669-78. PubMed ID: 20494393
[TBL] [Abstract][Full Text] [Related]
10. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece.
Kosma CI; Lambropoulou DA; Albanis TA
J Hazard Mater; 2010 Jul; 179(1-3):804-17. PubMed ID: 20395039
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology.
Salgado R; Noronha JP; Oehmen A; Carvalho G; Reis MA
Water Sci Technol; 2010; 62(12):2862-71. PubMed ID: 21123916
[TBL] [Abstract][Full Text] [Related]
12. Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan.
Lin AY; Lin CF; Tsai YT; Lin HH; Chen J; Wang XH; Yu TH
Water Sci Technol; 2010; 62(10):2450-8. PubMed ID: 21076233
[TBL] [Abstract][Full Text] [Related]
13. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
Kreuzinger N; Clara M; Strenn B; Kroiss H
Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
[TBL] [Abstract][Full Text] [Related]
14. Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants.
Okuda T; Yamashita N; Tanaka H; Matsukawa H; Tanabe K
Environ Int; 2009 Jul; 35(5):815-20. PubMed ID: 19201472
[TBL] [Abstract][Full Text] [Related]
15. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
[TBL] [Abstract][Full Text] [Related]
16. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan.
Lin AY; Yu TH; Lateef SK
J Hazard Mater; 2009 Aug; 167(1-3):1163-9. PubMed ID: 19269086
[TBL] [Abstract][Full Text] [Related]
17. Efficiency, costs and benefits of AOPs for removal of pharmaceuticals from the water cycle.
Tuerk J; Sayder B; Boergers A; Vitz H; Kiffmeyer TK; Kabasci S
Water Sci Technol; 2010; 61(4):985-93. PubMed ID: 20182078
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
[TBL] [Abstract][Full Text] [Related]
19. Biological removal of pharmaceuticals and personal care products during laboratory soil aquifer treatment simulation with different primary substrate concentrations.
Onesios KM; Bouwer EJ
Water Res; 2012 May; 46(7):2365-75. PubMed ID: 22374299
[TBL] [Abstract][Full Text] [Related]
20. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
Esplugas S; Bila DM; Krause LG; Dezotti M
J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
